节点文献
苯卓昔芬对健康绝经后妇女骨代谢及血脂的影响
Effect of bazedoxifene on biochemical markers of bone metabolism and serum lipids in healthy Chinese postmenopausal women
【摘要】 目的:评价苯卓昔芬对健康绝经后妇女骨代谢指标及血脂的影响。方法:采用双盲、随机、安慰剂对照研究,将45例健康的绝经后妇女随机分3组:苯卓昔芬(BZ)20mg组12例、BZ40mg组13例、安慰剂组(PL)20例,各组均每日服用苯卓昔芬及钙尔奇各1片,连服3月。服药前后测定骨代谢生化指标及血脂水平。结果:骨代谢指标变化:BZ40mg组的血、尿C端交联多肽(s-CTx,u-CTx)、尿N端交联多肽(u-NTx)及血清骨钙素(BGP)水平均较基础值明显下降(P<0.001),与PL组比较均出现统计学显著性差异(P<0.05);BZ20mg组的u-CTx,s-CTx,u-NTx下降显著(P<0.05),与PL组比较仅s-CTx出现统计学差异(P<0.05)。血脂变化:各组用药后HDL-C水平均上升(P<0.01),BZ组与PL组比较无统计学差异(P>0.05)。BZ40mg组LDL-C水平下降5.45%(P<0.05),20mg组下降1.74%,PL组上升0.77%,与PL组比较BZ40mg组出现统计学差异(P<0.05)。BZ20mg或40mg对总胆固醇及甘油三脂未产生显著影响。BZ组无严重不良事件发生。结论:苯卓昔芬可以降低骨代谢指标、升高HDL-C、降低LDL-C水平,对健康绝经后妇女具有良好的安全性及耐受性。
【Abstract】 Objective:To determine the effect of bazedoxifene acetate(20 and 40 mg)on serum biochemical markers of bone metabolism and lipids in healthy Chinese postmenopausal women.Methods:In a randomized,double-blind,placebo-control trial,a total of 45 healthy postmenopausal women were treated with bazedoxifene at either 20 mg(n=12)or 40 mg(n=13),or with placebo(n=20)daily for 3 months.In addition,all the women took elemental calcium,600 mg daily for 3 months.Serum lipids and bone biochemical markers were determined before and after drug administration.Results:Bazedoxifene at 40 mg significantly decreased the biochemical markers of bone metabolism(P<0.05),including urine N-telopetide(u-NTx),C-telopetide(u-CTx),serum C-telopetide(s-CTx)and osteocalcin,as compared to placebo group.Bazedoxifene at 20 mg decreased u-CTx,u-NTx and s-CTx,but only significantly decreased s-CTx as compared to placebo(P<0.05).At 3 months,both 20 and 40 mg bazedoxifene significantly increased the high-density lipoprotein cholesterol(P<0.01)from the baseline values,but did not differ from the values of placebo group(P>0.05).Bazedoxifene decreased the low-density lipoprotein cholesterol by 5.45%(P<0.05)at 40 mg,and by 1.74%(P>0.05)at 20 mg.No differences were found in total cholesterol or triglyceride levels between the bazedoxifene(20 and 40 mg)and placebo groups(P>0.05).No severe side effects were found in each group.Conclusion:Bazedoxifene at 20 and 40 mg·d-1 for 3 months can decrease biochemical markers of bone metabolism,and has a benefitial effect on serum lipid profile in healthy Chinese postmenopausal women.
【Key words】 bazedoxifene; postmenopausal; bone metabolism markers; lipids;
- 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2009年16期
- 【分类号】R580
- 【下载频次】105